Anthropic Partners with Novo Nordisk for Drug Discovery, Details on Data Privacy Emerge
Anthropic has partnered with Novo Nordisk to integrate its Claude AI models into drug discovery processes, aiming to accelerate research and development. This new collaboration highlights Anthropic's expanding enterprise engagements, alongside reports that its commercial agreements, such as one with Charles Schwab, include strict clauses preventing the use of client data for model training, underscoring the company's commitment to data privacy in its partnerships.
3 articles from 3 outlets covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
3 outlets covered “Anthropic Partners with Novo Nordisk for Drug Discovery, Details on Data Privacy Emerge”. All of them report the following:
- Anthropic formed a partnership with Novo Nordisk
- The partnership aims to use AI for drug discovery
- Anthropic's Claude models are involved in the partnership
- Anthropic has an existing deal with Charles Schwab
- The Schwab deal includes a clause preventing Anthropic from using Schwab's data for model training
Which outlets covered this?
All 3 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.